1 in 20 Americans used ivermectin, hydroxychloroquine to treat COVID-19, study finds
A recent study has found 1 in 20 people in the U.S. who contracted COVID-19 used non-evidence based treatment, such as ivermectin and hydroxychloroquine, due to beliefs in vaccine-related misinformation.
The findings were shared in a study published in the JAMA Health Forum on Friday.
Researchers surveyed nearly 13,450 adults across the U.S. and focused on those who endorsed COVID-19 vaccine-related misinformation, distrusted hospitals, medical professionals, and scientists, and exhibited a greater belief in conspiracy theories, and found they were more likely to use unproven drugs to treat COVID-19.
Out of all study participants, six per cent reported using either ivermectin—an antiphrastic drug-- and hydroxychloroquine—a medicine to treat certain types of malaria and lupus as treatment for their COVID-19 infection.
The study’s survey was conducted between December 2022 and January 2023 and included U.S. residents 18 years and older who reported prior COVID-19 infection.
Researchers shared that despite the U.S. Food and Drug Administration denouncing the use of these medications for COVID-19 treatment, the number of prescriptions increased in the U.S., Canada and Australia during the first year of the pandemic.
The study also found that respondents who reported trust in social media and Donald Trump were most likely to have taken ivermectin or hydroxychloroquine, while those who trusted in physicians and hospitals were less likely to.
Of the participants, 2,461 out of 10,718 said they endorsed at least one piece of vaccine-related misinformation.
The study also showed that males, people with a college degree, people with greater income and Hispanic people were more likely to have taken ivermectin or hydroxychloroquine. Those aged 65 years and older were associated with being less likely to use a non-evidence based treatment, researchers said.
“These results suggest that the potential harms of misinformation may extend to the use of ineffective and potentially toxic treatments in addition to avoidance of health-promoting behaviours, such as vaccination,” the study concluded.
CTVNews.ca Top Stories

Federal dental insurance program to be phased in over 2024, benefits to start in May
The new federal dental insurance plan will be phased in gradually over 2024, with the first claims likely to be processed in May, government officials said ahead of a formal announcement scheduled for Monday morning.
'We're trying not to break down': Sask. family desperate to find their loved one last seen in Toronto
The family of 39-year-old Lesley Sparvier has been trying to find and locate her after she left home on foot in Kahkewistahaw First Nation, Sask. on Nov. 28.
Buckingham Palace releases this year’s Christmas card
Buckingham Palace released an image of the Christmas card that King Charles III and Queen Camilla will be sending out this year.
Iowa man arrested in the death of a Nebraska Catholic priest
A man has been arrested in the stabbing death of a Catholic priest who was attacked over the weekend in a church rectory in a small Nebraska community, authorities said.
The Université de Moncton will not be getting a new name
The board of New Brunswick's Universite de Moncton has decided not to change the school's name despite concerns about its connection to a problematic historical figure.
Trump says he won't testify Monday at his New York fraud trial and sees no need to appear again
Donald Trump said Sunday he has decided against testifying for a second time at his New York civil fraud trial, posting on social media that he "VERY SUCCESSFULLY & CONCLUSIVELY" testified last month and saw no need to appear again.
Saskatchewan is a safe space to buy 'sustainable oil,' Scott Moe says
Saskatchewan Premier Scott Moe is working hard to use a global climate change conference as an opportunity to market the province’s non-renewable resources.
LCBO reveals what Ontarians drank the most this year
When it came to what Ontarians brought home during their liquor runs at the LCBO, the company said customers went for options that gave them more bang for their buck.
Al Gore calls UAE hosting COP28 'ridiculous,' slams oil CEO appointed to lead climate talks
Climate advocate and former Vice President Al Gore on Sunday called into question the decision to hold the COP28 climate talks in the United Arab Emirates, a leading producer of the world’s oil.